TherapeuticsMD (TXMD) Operating Margin (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Operating Margin came in at 99.86% in Q1 2026, up 22609.0% YoY from N/an in Q1 2025, and up 42.54% on a QoQ basis from 173.8% in Q4 2025.
TherapeuticsMD (TXMD) Operating Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 16 years of Operating Margin data on file, last reported at 99.86% in Q1 2026.
- Quarterly Operating Margin rose 22609.0% year-over-year to 99.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 114.29% (up 20380.0% YoY) and the FY2025 annual result came in at 145.27%, up 20181.0% from the prior year.
- Operating Margin grew to 99.86% in Q1 2026, from 173.8% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 70.65% in Q4 2022 to a low of 4269.25% in Q2 2022.
- A 5-year average of 1083.05% and a median of 343.5% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2022 — Operating Margin slumped 411631 bps — and 2023, when it surged 370358 bps.
- Tracing TXMD's Operating Margin over 5 years: stood at 70.65% in 2022, then plunged by 586 bps to 343.5% in 2023, then jumped by 72 bps to 97.75% in 2024, then tumbled by 78 bps to 173.8% in 2025, then surged by 43 bps to 99.86% in 2026.
- The last three Operating Margin figures came in at 99.86% (Q1 2026), 173.8% (Q4 2025), and 109.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.50 Bn | 39.84 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 32.56 Bn | 30.88 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.31 Bn | 19.65 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TherapeuticsMD | 23.96 Mn | 14.77 Mn | - | -93.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.90% |
| Mar 31, 2026 | -99.86% |
| Dec 31, 2025 | -173.80% |
| Sep 30, 2025 | -109.95% |
| Jun 30, 2025 | -73.00% |
| Mar 31, 2025 | -325.95% |
| Dec 31, 2024 | -97.75% |
| Sep 30, 2024 | -207.31% |
| Jun 30, 2024 | -1,191.88% |
| Mar 31, 2024 | -364.86% |
| Dec 31, 2023 | -343.50% |
| Sep 30, 2023 | -3,345.28% |
| Jun 30, 2023 | -565.68% |
| Mar 31, 2023 | -641.11% |
| Dec 31, 2022 | 70.65% |
| Sep 30, 2022 | -4,101.41% |
| Jun 30, 2022 | -4,269.25% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | -189.48% |
| Sep 30, 2021 | -157.13% |